Terifrac 750 mcg – Composition, Uses and Medicine Enquiries
Product Overview
Terifrac 750 mcg contains Teriparatide, a medicine related to natural parathyroid hormone that stimulates new bone formation.
It is prescribed for selected patients with severe osteoporosis who are at high risk of fractures, including eligible postmenopausal women and men.
Unlike medicines that mainly slow bone breakdown, Teriparatide promotes bone building.
The product is given by subcutaneous injection using the appropriate device, with treatment duration and monitoring decided by a clinician.
Calcium levels, kidney-stone history and other medical factors may affect suitability.
The listed 750 mcg refers to the cartridge content, not a single injection dose. The exact product presentation should be verified against the actual manufacturer-labelled packaging before publishing this product page.
Composition and Strength
The supplied product information identifies the following composition:
| Active Ingredient | Strength |
|---|---|
| Teriparatide | 750 mcg per 3 mL cartridge |
Product Name: Terifrac 750 mcg
Generic Name: Teriparatide
Brand Name: Terifrac
Strength: 750 mcg per 3 mL cartridge
Presentation: Cartridge — verify against the actual manufacturer-labelled product.
Please verify the exact cartridge presentation, formulation and manufacturer details against the original product packaging before publishing this product page or proceeding with an enquiry.
Therapeutic Category and Indication
Terifrac 750 mcg belongs to the osteoporosis medicine category and is classified as a parathyroid hormone analog.
Its clinical use relates to severe osteoporosis in patients at high fracture risk.
It is prescribed for selected patients with severe osteoporosis who are at high risk of fractures, including eligible postmenopausal women and men.
Unlike medicines that mainly slow bone breakdown, Teriparatide promotes bone building.
Treatment decisions depend on diagnosis, patient-specific factors, coexisting conditions, interactions and the applicable approved product information.
The listed indications are a general overview, not a substitute for a prescriber’s assessment. The exact approved uses and restrictions should be checked against the product’s current local prescribing information.
Administration Information
Terifrac should be administered subcutaneously using the correct pen device after training from a healthcare professional.
Patients should follow the prescribed daily dose and storage instructions. The entire cartridge should not be injected as a single dose.
The prescribed schedule, duration, missed-dose instructions and monitoring requirements must be provided by the treating clinician.
Patients should not start, switch or stop prescription therapy on the basis of website information.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: Terifrac 750 mcg
- Generic Name: Teriparatide
- Brand Name: Terifrac
- Strength: 750 mcg per 3 mL cartridge
- Therapeutic Category: Osteoporosis
- Medicine Class: Parathyroid Hormone Analog
- Indication: Severe osteoporosis in patients at high fracture risk.
- Presentation: 3 mL cartridge — verify actual presentation.
The dosage form and pack size must be matched to the actual manufacturer-labelled presentation.
Available packaging, batch identification, expiry date and remaining shelf life may vary and should be confirmed by an authorised supplier before any transaction.
No pack quantity, stock position or export eligibility is guaranteed by this listing.
Prescription and Patient Safety
Terifrac is a prescription medicine that requires appropriate medical supervision.
Calcium levels, kidney-stone history and other medical factors may affect suitability.
Treatment duration and monitoring requirements should be determined by the treating clinician.
Patients should follow the prescribed daily dose and storage instructions and use the appropriate injection device after professional training.
The exact precautions, monitoring requirements and possible adverse effects should be checked against the current approved product information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal receives medicine-related enquiries and may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.
Medinglobal does not itself manufacture, dispense, sell or export this medicine.
Availability, prescription requirements, lawful supply routes, supporting documents and any destination-country restrictions must be confirmed by the relevant authorised provider.
Submission of an enquiry is not a commitment or guarantee of supply.
How to Submit a Terifrac 750 mcg Enquiry
To help identify the requested product, include the following details when submitting an enquiry:
- Product or brand name: Terifrac 750 mcg.
- Generic name: Teriparatide.
- Required strength and dosage form.
- Required quantity.
- Destination country.
- Whether the request is for an individual patient or a healthcare institution.
- Valid prescription or other supporting documentation, where required.
Medinglobal may refer the enquiry to an appropriately authorised independent partner for verification and response.
Any subsequent transaction is subject to the partner’s own legal, clinical and regulatory checks.
Frequently Asked Questions
What is Terifrac 750 mcg used for?
Terifrac 750 mcg is associated with severe osteoporosis in patients at high fracture risk. Eligibility and approved indications depend on the specific product label and clinician assessment.
What does Terifrac 750 mcg contain?
The supplied product information identifies Teriparatide 750 mcg per 3 mL cartridge. The precise formulation and presentation should be verified against the original product packaging.
Does 750 mcg refer to a single injection dose?
No. The supplied product information specifies that 750 mcg refers to the cartridge content, not a single injection dose.
Can I use this medicine without medical advice?
No. Prescription medicines and specialist therapies require qualified clinical oversight.
Can international patients enquire through Medinglobal?
Enquiries may be submitted, but lawful coordination and any supply depend on authorised partners and applicable local rules.
Does Medinglobal sell or dispense Terifrac directly?
No. Medinglobal receives medicine-related enquiries and may help communicate with independent, appropriately authorised pharmaceutical suppliers or service providers. It does not itself manufacture, dispense, sell or export this medicine.
Reviews
There are no reviews yet.